Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
|---|
| Stockholders' Equity |
|
| Schedule of Stock-Based Compensation Expense |
The following table summarizes the stock-based compensation expense from stock option, employee stock purchase programs and restricted Common Stock awards and warrants for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
($ in thousands) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Fortress: |
|
|
|
|
|
|
|
|
|
|
|
|
Employee and non-employee awards |
|
$ |
2,249 |
|
$ |
2,271 |
|
$ |
4,442 |
|
$ |
4,708 |
Executive awards |
|
|
273 |
|
|
410 |
|
|
497 |
|
|
817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Partner Companies: |
|
|
|
|
|
|
|
|
|
|
|
|
Avenue |
|
|
192 |
|
|
27 |
|
|
383 |
|
|
38 |
Checkpoint |
|
|
1,171 |
|
|
567 |
|
|
1,881 |
|
|
1,536 |
Mustang |
|
|
(619) |
|
|
45 |
|
|
(542) |
|
|
280 |
Journey |
|
|
1,674 |
|
|
873 |
|
|
3,080 |
|
|
1,519 |
Other |
|
|
58 |
|
|
24 |
|
|
115 |
|
|
50 |
Total stock-based compensation expense |
|
$ |
4,998 |
|
$ |
4,217 |
|
$ |
9,856 |
|
$ |
8,948 |
|
| Schedule of Stock Option Activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average |
|
|
|
|
|
|
|
Total |
|
remaining |
|
|
|
|
Weighted average |
|
weighted average |
|
contractual life |
|
|
Number of shares |
|
exercise price |
|
intrinsic value |
|
(years) |
Options vested and expected to vest at December 31, 2023 |
|
18,896 |
|
$ |
20.55 |
|
$ |
— |
|
1.76 |
Granted |
|
540,000 |
|
|
1.68 |
|
|
16,200 |
|
6.71 |
Options vested and expected to vest at June 30, 2024 |
|
558,896 |
|
$ |
2.32 |
|
$ |
16,200 |
|
6.52 |
Options vested and exercisable at June 30, 2024 |
|
18,896 |
|
$ |
20.55 |
|
$ |
— |
|
1.26 |
|
| Schedule of Restricted Stock Awards and Restricted Stock Units |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
average grant |
|
|
Number of shares |
|
price |
Unvested balance at December 31, 2023 |
|
1,458,700 |
|
$ |
28.05 |
Restricted stock granted |
|
443,024 |
|
|
3.01 |
Restricted stock vested |
|
(17,303) |
|
|
35.76 |
Restricted stock units granted |
|
37,500 |
|
|
1.84 |
Restricted stock units forfeited |
|
(10,582) |
|
|
11.43 |
Restricted stock units vested |
|
(49,684) |
|
|
39.61 |
Unvested balance at June 30, 2024 |
|
1,861,655 |
|
$ |
21.27 |
|
| Schedule of Warrant activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total weighted |
|
Weighted average |
|
|
|
|
|
|
|
average |
|
remaining |
|
|
Number of |
|
Weighted average |
|
intrinsic |
|
contractual life |
|
|
shares |
|
exercise price |
|
value |
|
(years) |
Outstanding as of December 31, 2023 |
|
5,787,289 |
|
$ |
1.88 |
|
$ |
7,794,450 |
|
4.91 |
Issued |
|
3,506,140 |
|
|
3.12 |
|
|
8,113 |
|
— |
Exercised |
|
(17,500) |
|
|
1.70 |
|
|
— |
|
— |
Outstanding as of June 30, 2024 |
|
9,275,929 |
|
$ |
2.35 |
|
$ |
64,538 |
|
4.46 |
Exercisable as of June 30, 2024 |
|
9,275,929 |
|
$ |
2.35 |
|
$ |
64,538 |
|
4.46 |
|